Survival and morbidity in elderly patients treated with cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a population-based study | Synapse
March 3, 2026Open Access
Survival and morbidity in elderly patients treated with cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a population-based study
Key Points
Survival rates improve for elderly patients undergoing cytoreductive surgery and HIPEC, contrary to age-related concerns.
Proposed analysis shows that age >74 does not necessarily increase postoperative morbidity or complications post-surgery.
Population-based study assessed outcomes in patients undergoing cytoreductive surgery with HIPEC for colorectal metastases.
Findings highlight that careful patient selection can lead to favorable surgery outcomes for seniors.
Abstract
These results indicate that age above 74 should not automatically exclude patients from undergoing CRS-HIPEC. Careful selection ensures favorable survival without an increase in postoperative morbidity.